Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®)
Open Access
- 19 July 2014
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in BMC Urology
- Vol. 14 (1), 53
- https://doi.org/10.1186/1471-2490-14-53
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- α‐blockers, antibiotics and anti‐inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndromeBJU International, 2012
- Mechanisms in Prostatitis/Chronic Pelvic Pain SyndromeJournal of Urology, 2008
- Chronic Prostatitis/Chronic Pelvic Pain SyndromeUrologic Clinics of North America, 2008
- Preventive and therapeutic administration of an indigenous Lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse modelAntonie van Leeuwenhoek, 2005
- A Prospective, 1-Year Trial Using Saw Palmetto Versus Finasteride in the Treatment of Category III Prostatitis/Chronic Pelvic Pain SyndromeJournal of Urology, 2004
- Long-term Results of Multimodal Therapy for Chronic Prostatitis/chronic Pelvic Pain SyndromeJournal of Urology, 2003
- Antimicrobial Treatment of Bacterial ProstatitisEuropean Urology Supplements, 2003
- Summary Consensus Statement: Diagnosis and Management of Chronic Prostatitis/Chronic Pelvic Pain SyndromeEuropean Urology Supplements, 2003
- Sickness Impact of Chronic Nonbacterial Prostatitis and its CorrelatesJournal of Urology, 1996
- Intra-prostatic Urinary Reflux: an Aetiological Factor in Abacterial ProstatitisBritish Journal of Urology, 1982